BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
25 results:

  • 1. Investigation of the activity of a novel tropolone in osteosarcoma.
    Haney SL; Feng D; Kollala SS; Chhonker YS; Varney ML; Williams JT; Ford JB; Murry DJ; Holstein SA
    Drug Dev Res; 2024 Feb; 85(1):e22129. PubMed ID: 37961833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 3-AP inhibits the growth of human osteosarcoma by decreasing the activity of the iron-dependent pathway.
    Huang S; Zhang D; Yi X; Liu C; Jian C; Yu A
    Med Oncol; 2023 Nov; 40(12):353. PubMed ID: 37952032
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dysregulation of iron homeostasis by TfR-1 renders EZH2 wild type diffuse large B-cell lymphoma resistance to EZH2 inhibition.
    Yu L; Wang YF; Xiao J; Shen QQ; Chi SS; Gao YL; Lin DZ; Ding J; Fang YF; Chen Y
    Acta Pharmacol Sin; 2023 Oct; 44(10):2113-2124. PubMed ID: 37225847
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel t(1;8)(p31.3;q21.3) NFIA-RUNX1T1 Translocation in an Infant Erythroblastic Sarcoma.
    King RL; Siaghani PJ; Wong K; Edlefsen K; Shane L; Howard MT; Reichard KK; Mai M; Viswanatha DS; Greipp PT; Goble TA; Ruiz M; Hara H
    Am J Clin Pathol; 2021 Jun; 156(1):129-138. PubMed ID: 33313700
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
    Wu H; Zhang J; Dai R; Xu J; Feng H
    J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
    Zhao L; He R; Long H; Guo B; Jia Q; Qin D; Liu SQ; Wang Z; Xiang T; Zhang J; Tan Y; Huang J; Chen J; Wang F; Xiao M; Gao J; Yang X; Zeng H; Wang X; Hu C; Alexander PB; Symonds ALJ; Yu J; Wan Y; Li QJ; Ye L; Zhu B
    Nat Med; 2018 Oct; 24(10):1536-1544. PubMed ID: 30297899
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Physical Therapist Clinical Reasoning and Action for Individuals With Undiagnosed Lower Extremity Tumors: A Report of 3 Cases.
    Peterson S; Denninger T; Porter S
    J Orthop Sports Phys Ther; 2017 May; 47(5):359-366. PubMed ID: 28355977
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor.
    Kern JB; Hii A; Kruse MJ; Szabo Z; Argani P; Hibbard MK; Gladstone DE; Meyer C; Zheng R; Borowitz MJ; Duffield AS
    Int J Surg Pathol; 2015 Feb; 23(1):75-7. PubMed ID: 25305220
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies.
    Rienzo M; Schiano C; Casamassimi A; Grimaldi V; Infante T; Napoli C
    Clin Transl Oncol; 2013 Mar; 15(3):211-8. PubMed ID: 22855186
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Erythroblastic sarcoma, an extremely rare variant of myeloid sarcoma.
    Cornfield DB
    Hum Pathol; 2012 Nov; 43(11):2080-3. PubMed ID: 22795354
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
    Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
    J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia.
    Tsagarakis NJ; Argyrou A; Gortzolidis G; Kentrou N; Papadhimitriou SI; Tzanetou K; Kakiopoulos G; Papadimitriou KA; Skoumi D; Paterakis G
    Int J Hematol; 2009 Jul; 90(1):94-98. PubMed ID: 19484335
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Antitumor action of lymphokin-activated cells of patients with soft tissue sarcomas and melanomas in dependence on expression of MHC classes I and II antigenes.
    Berezhnaya NM; Vinnichuk UD; Belova OB; Baranovich VV
    Exp Oncol; 2006 Sep; 28(3):231-4. PubMed ID: 17080018
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of tumor-derived transforming growth factor-beta1 (TGF-beta1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma.
    Thakur VS; Shankar B; Chatterjee S; Premachandran S; Sainis KB
    Cancer Immunol Immunother; 2005 Sep; 54(9):837-47. PubMed ID: 15726358
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I.
    Raile K; Hille R; Laue S; Schulz A; Pfeifer G; Horn F; Kiess W
    Horm Metab Res; 2003; 35(11-12):786-93. PubMed ID: 14710359
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
    Farinola MA; Weir EG; Ali SZ
    Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
    Czader M; Ali SZ
    Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unusual presentation of "extracavitary" primary effusion lymphoma in previously unknown HIV disease.
    Medeiros BC; Maness LJ; Bauer FA; Ross JW; Kapur D
    Conn Med; 2000 Oct; 64(10):591-4. PubMed ID: 11100630
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients.
    Vlk V; Eckschlager T; Kavan P; Kabícková E; Koutecký J; Sobota V; Bubenik J; Pospísilová D
    Pediatr Hematol Oncol; 2000; 17(1):31-44. PubMed ID: 10689713
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion.
    Gogusev J; Nezelof C
    Hematol Oncol Clin North Am; 1998 Apr; 12(2):445-63. PubMed ID: 9561912
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.